Genomica opens first subsidiary in the Chinese city of Wuhan to grow in the country and in other Asia Pacific markets
Genomica abre su primera filial en la ciudad china de Wuhan para crecer en el país y en otros mercados de Asia Pacífico
Intel ID : 257469
|
||||
| Intel ID | 257469 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - PharmaMar
(31 Dec 2021) |
Revenue: - EBITDA: - Net Debt: - |
||
| Date |
 |
||
| Country |  |
||
| Region | |||
| Continent | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.03 Diagnostic, Imaging & Laboratory Services 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Ultimate Owner (Buyer)
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Radar
| Date | Title | Type | Intel Grade | Country | Subsector | ||
|
|
|
|
|
|
|
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.